Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
ConditionIschemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorXijing Hospital
About this trial
To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.
Eligibility criteria
Qualifiers
Patients diagnosed clinically as ischemic stroke;
Age ≥ 40 years;
Onset time ≤ 3 months;
Informed consent was signed.
Disqualifiers
Patients with symptomatic intracranial hemorrhage;
bleeding lesion > 10 mm was found on SWI;
Vascular malformations, tumors, abscesses or other major non ischemic brain diseases were present;
There are contraindications for antithrombotic drugs use;
Trial design
Treatments tested in this trial
- Antithrombotic drugs
Treatment groups
No treatment groups listed
Sponsors and collaborators
Xijing Hospital
Lead sponsor
Ankang Central Hospital
Collaborator
Yan'an University Affiliated Hospital
Collaborator
Source ClinicalTrials.gov